Carl Gordon combines a Ph.D. in molecular biology from MIT with a CFA and early hands-on experience at ImClone Systems, giving him both deep scientific knowledge and direct industry experience before becoming an investor. As a founding General Partner and Co-Head of Global Private Equity at OrbiMed, he has been recognized multiple times on Forbes' Midas List and rarely gives interviews despite being frequently sought after for high-level biotech sector insights. Carl Gordon combines a Ph.D. in molecular biology from MIT with a CFA and early hands-on experience at ImClone Systems, giving him both deep scientific knowledge and direct industry experience before becoming an investor. As a founding General Partner and Co-Head of Global Private Equity at OrbiMed, he has been recognized multiple times on Forbes' Midas List and rarely gives interviews despite being frequently sought after for high-level biotech sector insights.